Private Equity
'The combination of zero churn, a rapidly growing enterprise pipeline and a market that is still at the very beginning of cloud adoption underpins our conviction in the opportunity ahead,' says Verdane's Dominik Schwarz.
4 min read · 19 May 2026
In conjunction with this transaction, Geoffrey Pestes has been promoted to CEO following more than a decade leading operations at the company.
1 min read · 18 May 2026
Aleris provides specialist care to patients in more than 100 clinics in Sweden, Norway and Denmark.
3 min read · 18 May 2026
The combined company will operate under the Tecomet name.
1 min read · 15 May 2026
Barb Jacobsmeyer serves as president and CEO of Enhabit.
1 min read · 15 May 2026
Discussing the platform and M&A opportunities firms see in the pharmaceutical and life science sector; a look at Eir Partners’ investment in a life sciences data analytics company; insights from a conference hosted by Houlihan Lokey on what’s needed to leverage AI to help businesses thrive in the era of disintermediation.
5 min read · 15 May 2026
Blackstone, Audax, Bridgepoint and Baird are among the PE firms targeting add-ons for pharmaceutical and life science consultancy platforms.
5 min read · 15 May 2026
Based in Lewisville, Texas, GMR is a provider of emergency medical services.
1 min read · 13 May 2026
QuartzBio provides sample and biomarker intelligence for clinical‑stage biopharma.
1 min read · 13 May 2026
Vitaly Group is an Iberian occupational health and safety services provider.
1 min read · 13 May 2026